0001209191-21-012347.txt : 20210219
0001209191-21-012347.hdr.sgml : 20210219
20210219161818
ACCESSION NUMBER: 0001209191-21-012347
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210217
FILED AS OF DATE: 20210219
DATE AS OF CHANGE: 20210219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 21655836
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-17
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Adm, Leg & BD Off
Common Stock
2021-02-17
4
F
0
6240
211.75
D
44106
D
Common Stock
2021-02-18
4
S
0
1007
210.08
D
43099
D
Common Stock
2021-02-18
4
S
0
4666
211.83
D
38433
D
Common Stock
2021-02-18
4
S
0
1952
212.56
D
36481
D
Common Stock
2021-02-18
4
S
0
200
213.45
D
36281
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $210.08 (range $209.60 to $210.54).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $211.83 (range $211.25 to $212.24).
Open market sales reported on this line occurred at a weighted average price of $212.56 (range $212.25 to $212.95).
Open market sales reported on this line occurred at a weighted average price of $213.45 (range $213.30 to $213.68).
/s/ Sabrina Yohai, Attorney-in-Fact
2021-02-19